GIP
BIIB icon

Greatmark Investment Partners’s Biogen BIIB Stock Holding History

Greatmark Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,645
Closed -$2.58M – 122
2022
Q2 		$2.58M Sell
12,645
-4,869
-28% -$995K 0.5% 46
2022
Q1 		$3.69M Buy
17,514
+3,735
+27% +$812K 0.61% 36
2021
Q4 		$3.31M Buy
13,779
+4,448
+48% +$1.14M 0.56% 38
2021
Q3 		$2.64M Buy
9,331
+206
+2% +$67.5K 0.49% 41
2021
Q2 		$3.16M Buy
9,125
+2,780
+44% +$842K 0.57% 39
2021
Q1 		$1.77M Buy
6,345
+1,870
+42% +$504K 0.35% 53
2020
Q4 		$1.1M Sell
4,475
-322
-7% -$83.1K 0.24% 58
2020
Q3 		$1.36M Buy
4,797
+847
+21% +$236K 0.34% 51
2020
Q2 		$1.06M Sell
3,950
-1,220
-24% -$367K 0.28% 57
2020
Q1 		$1.64M Sell
5,170
-5
-0.1% -$1.52K 0.53% 44
2019
Q4 		$1.54M Buy
5,175
+680
+15% +$189K 0.38% 51
2019
Q3 		$1.05M Buy
4,495
+410
+10% +$95.5K 0.29% 57
2019
Q2 		$955K Buy
4,085
+295
+8% +$68.1K 0.29% 59
2019
Q1 		$896K Buy
3,790
+35
+0.9% +$11K 0.28% 56
2018
Q4 		$1.13M Buy
3,755
+235
+7% +$75K 0.4% 49
2018
Q3 		$1.24M Buy
3,520
+45
+1% +$15.5K 0.39% 53
2018
Q2 		$1.01M Buy
3,475
+155
+5% +$43.6K 0.35% 55
2018
Q1 		$909K Sell
3,320
-15
-0.4% -$4.66K 0.33% 58
2017
Q4 		$1.06M Buy
3,335
+950
+40% +$305K 0.38% 55
2017
Q3 		$747K Buy
2,385
+1,180
+98% +$349K 0.29% 62
2017
Q2 		$327K Buy
1,205
+200
+20% +$52.9K 0.13% 80
2017
Q1 		$275K Sell
1,005
-375
-27% -$106K 0.11% 84
2016
Q4 		$391K Buy
1,380
+75
+6% +$22.2K 0.16% 72
2016
Q3 		$409K Buy
1,305
+15
+1% +$4.44K 0.18% 67
2016
Q2 		$312K Buy
+1,290
New +$340K 0.14% 73

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Greatmark Investment Partners's BIIB Position: Q3 2022 in Review

Greatmark Investment Partners sold out of Biogen (BIIB) in Q3 2022, closing a stake of 12,645 shares — an estimated $2.58M sold.

Greatmark Investment Partners first reported a position in BIIB in Q2 2016 and held it in 25 quarters. The position peaked at $3.69M in Q1 2022. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Greatmark Investment Partners reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Greatmark Investment Partners sold 12,645 Biogen shares in Q3 2022, an estimated $2.58M.
  • Greatmark Investment Partners first reported a position in Biogen in Q2 2016 and held it in 25 quarters.
  • Greatmark Investment Partners's Biogen position peaked at $3.69M in Q1 2022.
  • 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Greatmark Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.